Stay updated on CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThese are minor UI and labeling updates, including glossary show/hide options, capitalization adjustments in QC-related text, and a revision label, affecting none of the study content or page functionality; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check22 days agoChange DetectedThe page revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedFooter revision updated to v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 text were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page shows Revision: v3.3.2 replacing v3.2.0, a minor metadata update with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the government funding status banner; core trial details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedThe study PERSEA (NCT04049175) was terminated for futility after an interim analysis, with the sponsor issuing an early termination notice.SummaryDifference0.5%

Stay in the know with updates to CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.